Orion Investment Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.55M Sell
39,571
-39
-0.1% -$7.46K 2.49% 15
2026
Q1
$7.26M Buy
39,610
+206
+0.5% +$38K 2.3% 14
2025
Q4
$6.93M Sell
39,404
-25
-0.1% -$4.08K 2.11% 15
2025
Q3
$5.52M Buy
39,429
+6,528
+20% +$882K 1.76% 17
2025
Q2
$4.13M Buy
32,901
+1,249
+4% +$156K 1.46% 18
2025
Q1
$4.33M Sell
31,652
-69
-0.2% -$9.86K 1.77% 17
2024
Q4
$4.85M Sell
31,721
-834
-3% -$141K 1.94% 17
2024
Q3
$6.31M Sell
32,555
-88
-0.3% -$18.4K 2.45% 14
2024
Q2
$7.57M Buy
+32,643
New +$7.09M 3.01% 8

Other funds holding BIIB

Orion Investment Company's BIIB Position: Q2 2026 in Review

Orion Investment Company reduced its Biogen (BIIB) stake by 0.1% in Q2 2026, selling an estimated $7.46K and leaving 39,571 shares worth $8.55M. The position accounts for 2.49% of the portfolio, ranked #15.

Orion Investment Company first reported a position in BIIB in Q2 2024 and has held it in 9 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Orion Investment Company held 39,571 shares of Biogen worth $8.55M as of Q2 2026.
  • Orion Investment Company sold 39 Biogen shares in Q2 2026, an estimated $7.46K.
  • Biogen made up 2.49% of Orion Investment Company's portfolio in Q2 2026, its #15 holding.
  • Orion Investment Company first reported a position in Biogen in Q2 2024 and has held it in 9 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Orion Investment Company's 13F filing for Q2 2026, filed 11 Aug 2026.